Junevity
Junevity develops medicines targeting transcription factors to reverse diseases of aging.
$20M Seed ·
Source: fundraisingfox.com
All 2 rounds ↓Signals
Website registeredMar 15, 2022 (4 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $20M | — | fundraisingfox.com | |
| Seed | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
JS
Janine Sengstack FounderJH
John Hoekman Founder
Investors
Companies like Junevity
TTalus BioSeed · Sep 2026
FFive Alarm BioSeed · Feb 2023BBioAge Labs
NNewLimit$435M Series B+ · Jun 2026
SSplice Bio$140M Series B+ · Jun 2025
MMOMA Therapeutics$150M Series B+ · May 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/junevity (get a free API key).